AFTER DISCONTINUATION OF THE 1ST TUMOR NECROSIS FACTOR INHIBITOR (TNFI), NON-TNFI BIOLOGIC AGENTS HAVE SIMILAR RESPONSES BUT HIGHER SURVIVAL COMPARED TO A 2ND COURSE OF A DIFFERENT TNFI: LONG-TERM PROSPECTIVE OBSERVATIONAL STUDY OF PATIENTS WITH RHEUMATOID ARTHRITIS IN A TERTIARY HOSPITAL OF GREECE

被引：0

作者：

Flouri, I. D. ^{[1
]}

Repa, A. ^{[1
]}

Avgouslidis, N. ^{[1
]}

Kougas, N. ^{[1
]}

Fanouriakis, A. ^{[1
]}

Papalopoulos, I. ^{[1
]}

Adamichou, C. ^{[1
]}

Kyfonidou, P. ^{[1
]}

Kampouraki, E. ^{[1
]}

Terizaki, M. ^{[1
]}

Boumpas, D. T. ^{[2
]}

Bertsias, G. ^{[1
]}

Sidiropoulos, P. ^{[1
]}

机构：

[1] Univ Crete, Fac Med, Rheumatol Clin Immunol & Allergy, Iraklion, Greece

[2] Attikon Univ Hosp, Dept Internal Med 4, Athens, Greece

来源：

关键词：

D O I：

10.1136/annrheumdis-2017-eular.6817

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

FRI0236

引用

页码：574 / 574

页数：1